Genetic variations in the IL-27 gene have been proven to be associated with various types of human cancers and diseases. The purpose of the current study was to clarify the associations of the IL-27 rs153109 A>G and rs181206 T>C variants with human diseases using a meta-analysis study.
Background
Interleukin-27 (IL-27), which belongs to the IL-12 family, is a newly-discovered protein consisting of 2 subunits, p28 and the Epstein-Barr virus-induced gene 3 protein, and is mainly secreted by activated antigen-presenting cells [1, 2] . Human IL-27 gene, located on chromosome 16p11, consists of 5 exons and 4 introns, acting as a mediator between the adaptive and innate immune systems [3] . As a multifunctional gene, IL-27 can regulate the proliferation of naive T-cell and plays an effective role in inducing the production of interferon-gamma [4, 5] . In addition, IL-27 is also involved in the up-regulation of Th1 initiation and the down-regulation of Th2 factor GATA binding protein 3, and it is linked to inducing tumor-specific antitumor activity, mediated by CD8 + T cells [1, 5] . Mutations of IL-27 were recently reported to be susceptible to a variety of diseases, such as colorectal cancer, asthma, rheumatoid arthritis, ovarian cancer, Crohn's disease, nasopharyngeal carcinoma, and esophageal cancer [1, 6, 7] . Specifically, according to previous studies, 2 single-nucleotide polymorphisms (SNPs) of IL-27, 964A/G (rs153109) and 4730 T/C (rs181206), are commonly found to be associated with various diseases [6, 8] . For instance, a previous study investigated the association of IL-27 gene polymorphism with Crohn's disease (CD) risk in a Chinese Han population found remarkable association between IL-27 rs153109 and rs181206 polymorphisms and CD risks [8] . Moreover, previous studies also found that rs153109 polymorphism may be a protective factor for breast cancer in premenopausal women and is associated with decreased risk of lymph node metastasis in papillary thyroid cancer [9, 10] . Through the promotion of proinflammatory immune response, polymorphisms rs153109 and rs181206 of IL-27 reduce or delay common antitumor activities responded to by Th1 cytotoxic, increasing the susceptibility to diseases [7, 11, 12] . Therefore, IL-27 could be regarded as a candidate gene related to diverse diseases. Previous studies have also shown that variants of IL-27 are closely correlated with diseases, including numerous common cancers, such as colorectal cancer, nasopharyngeal carcinoma, and ovarian cancer [6, 13] , while some other studies have presented different results [14, 15] . Therefore, the current study was performed to investigate the potential relationships between the polymorphisms of IL-27, rs153109, and rs181206, and their susceptibility to diseases, and to evaluate the role of IL-27 as a biomarker for the diagnosis and prognosis of diseases.
Material and Methods

Search strategy
Potential studies were retrieved by a thorough literature search, with language restricted to English or Chinese, in the computerized bibliographic databases MEDLINE, Science Citation Index, PubMed, Embase, Current Contents Index, Chinese Biomedical, Chinese Journal Full-Text, and the Weipu Journal (last updated search was October 2014). We used the following highly sensitive search strategy: ("Interleukin-27" or "Interleukin 27" or "IL 27" or "IL-27" or "IL27") and ("Polymorphism, Genetic" or "polymorphism" or "polymorphisms" or "variants" or "SNP" or "mutation" or "genetic variants"). A manual search was also conducted to find other studies.
Inclusion and exclusion criteria
Retrieved studies were assessed based on the following criteria: (1) studies published in peer-reviewed journal and conducted in human populations; (2) case-control studies investigating the association between SNPs in IL-27 (rs153109 A>G or rs181206 T>C) and susceptibility and human diseases; (3) patients were confirmed by the diagnostic criteria for each disease type; (4) provided sufficient original data on the genotype frequencies of polymorphisms within the IL-27 genes; (5) genotype frequencies of IL-27 met Hardy-Weinberg equilibrium (HWE); (6) studies with overlapping data were only enrolled once. The exclusion criteria were: (1) failed to meet the criteria for study inclusion; (2) letters, abstracts, meta-analysis, reviews, or proceedings; (3) unpublished data; (4) studies without extractable and numerical data; (5) Caucasian population.
Study quality and data extraction
Newcastle-Ottawa Scale (NOS) criteria were applied to assess the methodological quality of all eligible trials [16] . These 3 perspectives were independently scored by 2 reviewers: (1) subject selection: 0~4; (2) subject comparability: 0~2; (3) clinical outcome: 0~3. Study with NOS scores ³7 were considered as good quality (range, 0~9). Following descriptive information were collected including author name, publication year, journal name, country, detection method, population, language, diseases types, SNP, genotype frequencies, allele frequencies, HWE test, and confirmation of diagnosis. Disagreements during the study inclusion process were settled through consultation with another reviewer.
Statistical analysis
The effect size, as represented by the unadjusted odds ratios (ORs) for the presence of the SNP in IL-27 in patients and controls, was calculated. A 95% confidence interval (95%CI) was tested for the pooled OR using Z test. [17] . Subgroup analyses were also conducted to clarify the substantial heterogeneity. Additionally, the effect of each single study on the overall estimate was determined by application of one-way sensitivity analysis. Further, Egger's linear regression test and funnel plot were employed to inspect the presence of publication bias [18, 19] . Data analyses were performed utilizing STATA software (Version 12.0, Stata Corp., College Station, TX, USA).
Results
Description of included studies
The initial search resulted in a total of 46 potentially eligible articles. After the removal of 1 duplicated study and 16 irrelevant articles, 29 articles remained for further review. Subsequently, 11 articles were regarded as unsuitable and were removed, and 18 articles included qualitative analysis were left. In addition, another study was removed due to absence of data integrity. Finally, 17 case-control studies including 4185 patients and 4077 controls were incorporated into the current analysis [1, [4] [5] [6] [7] [11] [12] [13] [14] [15] [20] [21] [22] [23] [24] [25] [26] . A flow diagram of study selection progress is displayed in Figure 1 . As for the diseases involved in the included studies, there were 16 diseases, including rheumatoid arthritis (RA) (Chen S, 2014 Table 1 .
Quantitative data synthesis
In the current study, 2 SNPs (rs153109 A>G, and rs181206 T>C) within the IL-27 gene were identified. Additionally, since significant heterogeneity existed, studies were stratified by disease type. Our results suggested that the carriers of the rs181206 Figure 3A , 3B and Table 2 ).
We further conducted sensitivity analyses to determine whether review conclusions were affected by any single study. We found that no single study affected the pooled ORs in the current meta-analysis ( Figure 4A-4D Table 2 . Meta-analysis of the association between IL-27 polymorphisms and various human diseases.
W -wild allele; M -mutant allele; WW -wild homozygote; WM -heterozygote; MM -mutant homozygote; RA -rheumatoid arthritis; OC -ovarian cancer; CD -Crohn's disease; ITP -immune thrombocytopenia; T1D -type 1 diabetes mellitus; CHB -chronic hepatitis B; LC -hepatitis B virus (HBV)-related liver cirrhosis; HCC -hepatocellular carcinoma; NPC -nasopharyngeal carcinoma; CRC -colorectal cancer; EC -esophageal cancer; SLE -systemic lupus erythematosus; HBV -hepatitis B virus; TB -tuberculosis; IBD -inflammatory bowel disease; UC -ulcerative colitis; COPD -chronic obstructive pulmonary disease; PCR-RFLP -polymerase chain reaction-restriction fragment length polymorphism.
and IL-27p28, a predicted cytokine-like protein with 4-alpha helix bundle, forming functional IL-27 [31] . IL-27, structurally linked with IL-12 and IL-23, engages a receptor of gp130 and the IL-27Ra, which could activate JAK-signal transducer, an activator of transcription and signaling of mitogen-activated protein kinase [32] . Through promoting the proliferation of T cell and inducing the production of IFN-g, IL-27 could act as a TH1 type immune response initiator to take part in host defense against pathogen infections and by suppressing effector and memory T cells expansion and inhibiting cytokine secretion, such as TH1, TH2, and TH17, IL-27, which could also act as an immune inflammatory response attenuator to participate in autoimmunity and infection [33] . IL-27 also induces tumor-specific antitumor activity, mainly by mediating CD8 + T cells with enhancement of CTL activity [11] . It has been reported that IL-27 is connected with inflammatory and autoimmunity diseases and cancer by modulating Tr-1 cells, Tfh, Treg, and other linked immune cells [34] . Human IL-27 gene consists of 5 exons, with rs153109 (-964 A/G), rs181206 (4730 T/C) in the promoter of the IL-27 gene, which could modulate the expression of IL-27 [6] . Recently, increasing data found that the rs153109 and rs181206 in IL-27 gene was associated with risk of asthma [35] . One mechanism could be the polymorphism of rs153109 of the IL-27 gene just located in the disease-related locus such as UC and CD, suggesting the association with susceptibility to UC and CD [5] . Another possible mechanism is that different haplotypes and genotypes of the IL-27 gene may vary in the expression of IL-27, thus playing various roles in the progression of diseases. It was reported that the IL-27 964A/G AG genotype and IL-27 gene TGG haplotype could protect the progression of COPD, while the G allele in IL-27 964A/G might also be related to the susceptibility to SLE [21] . rs153109 is located in the promoter of IL-27, which could play a crucial role in initiating the transcription and protein expression regulation, which was associated with epithelial ovarian cancer [7] . In addition, IL-27 could trigger the proliferation of naive T-cells and implicated in the development of EC by inhibiting Th1 cytotoxic response to the delayed acquisition of common antitumor activities [6] . We conclude from the above analysis that the polymorphisms of IL-27 participate in many diseases because of the location in the disease-related area and the promoter, and different genotypes and haplotypes of 
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In conclusion, our results are consistent with other studies reporting that the polymorphisms of rs153109 and rs181206 in the IL-27 gene have a close relationship with many diseases, suggesting the IL-27 gene polymorphisms may be important in disease diagnosis and prognosis.
Some limitations of our study need to be noted. Firstly, only 2 SNPs (rs153109 and rs181206), widely discussed in various research, were investigated in our study. Additional genomic loci (such as rs17855750) should be covered in larger samples and with a broader coverage of genetic variation across the human genome [33] . Moreover, although the current study covers a great range of human diseases in Asian populations, the sample size for each disease was rather limited. Finally, further investigations to identify IL-27 rs153109 and rs181206 polymorphisms with human diseases are needed to validate and confirm our results. 
Conclusions
Taken together, our findings suggest that the genetic polymorphism of IL-27 rs153109 and rs181206 may be involved in the progression of human cancers and diseases, especially of TB, UC, COPD, OC, and ITP. Clinical studies and functional analyses are required to investigate the mechanisms underlying the association of other genomic loci in the IL-27 gene or the role of the IL-12 cytokine family with the risk of human cancers and diseases.
